No Photo Available

Last Update

2006-10-05T00:00:00.000Z

This profile was last updated on .

Is this you? Claim your profile.

Wrong Achim Knappik?

Dr. Achim Knappik

Senior Director Research and Development

A-by-D

Get ZoomInfo Grow

+ Get 10 Free Contacts a Month

Please agree to the terms and conditions

I agree to the Terms of Service and Privacy Policy. I understand that I will receive a subscription to ZoomInfo Grow at no charge in exchange for downloading and installing the ZoomInfo Contact Contributor utility which, among other features, involves sharing my business contacts as well as headers and signature blocks from emails that I receive.

A-by-D

Background Information

Employment History

Senior Director of Research and Development

Antibodies

Head

R&D

Research and Development Group Manager

Bio-Rad Laboratories Inc

Head of Research and Development

AbD Serotec Ltd

Senior Director

MorphoSys AG

Education

PhD

Web References (26 Total References)


AbD Serotec

www.a-by-d.com [cached]

Achim Knappik and Hartmut Merz

...
by Achim Knappik, Bettina Boelter and Hartmut Merz
...
Achim Knappik, PhD, Senior Director R&D of A-by-D, speaks to NGP about the benefits of new antibody design technologies
CHEManager, 11/2004, Vol 4, Reprint, pp32-33 : Screening Trends in Drug Discovery
"From Antigen Sequence to Antibody in Record Time.Two Innovative Technologies Combined for the High-Throughput..."
Achim Knappik and Christoph Hüls"
...
Achim Knappik, Hartmut Merz (Medizinische Universität Schleswig Holstein, Campus Lübeck)
...
Dr. Achim Knappik : "Synthetic Recombinant Antibodies" (in japanese language)


Achim Knappik, PhD, Senior ...

www.abdserotec.com [cached]

Achim Knappik, PhD, Senior Director R&D of A-by-D, speaks to NGP about the benefits of new antibody design technologies


Dr Achim Knappik of AbD ...

www.abdserotec.com [cached]

Dr Achim Knappik of AbD Serotec describes the use of recombinant anti-idiotypic antibodies as specialized tools in the development of preclinical and clinical research assays for antibody drug development and how they are generated using proprietary HuCAL® recombinant antibody generation technology.


Hear how AbD Serotec's HuCAL ® ...

www.abdserotec.com [cached]

Hear how AbD Serotec's HuCAL ® technology can be used to generate recombinant anti-drug antibodies for PK and immunogenicity assays in a presentation by Dr Achim Knappik, Head of R&D.


Dr. Achim Knappik, Head of ...

www.oem.abdserotec.com [cached]

Dr. Achim Knappik, Head of R&D at AbD Serotec commented, "Today's news further exemplifies the unique flexibility of our HuCAL antibody platform and the broad range of potential applications which we can target. e2v's approach to establish a novel type of point of care system is highly innovative and very interesting both scientifically and commercially.

Similar Profiles

Other People with this Name

Other people with the name Knappik

Siegfried Knappik
ITW Trans Tech

Fabian Knappik
MAN AG

Gregor Knappik
Atmel Corporation

Klaus Knappik
MLA International Consulting

Sarah Knappik
TV

City Directory Icon

Browse ZoomInfo's Business Contact Directory by City

People Directory Icon

Browse ZoomInfo's
Business People Directory

Company Directory Icon

Browse ZoomInfo's
Advanced Company Directory